Scholars Central

Conference abstractPublished 5 Mar 2012

Subretinal Delivery of EIAV-based Lentiviral Vectors in the Shaker1 mouse model for Usher Syndrome Type 1B : Development of UshStat

Authors: Dominic Cosgrove, Marisa Zallocchi, Katie Binley, Yatish Lad, Scott Ellis, Sylvie Wise, Martin Bussi�res, Peter Widdowson, Kyri Mitrophanous, You-Wei Peng, Wei-Min Wang, Linda Cheung, Duane Delimont

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Usher syndrome type 1B is a combined deaf-blindness condition caused by mutations in the MYO7A gene. The loss of function of Myo7A protein in the RPE and photoreceptors leads to blindness. We have evaluated the impact of subretinally delivered UshStat � , a recombinant minimal equine infectious anaemia virus- (EIAV) based vector expressing human MYO7A, on photoreceptor function in response to different light intensities in shaker1 mice, a mouse model of Usher type 1 B. Subretinal injections of EIAV CMV GFP or EIAV CMV MYO7A (UshStat � ) were performed in shaker1 mice. Photoreceptor function in EIAV CMV MYO7A treated eyes was determined histologically by evaluating alpha-transducin translocation in photoreceptors in response to low and high light levels. In addition, the neuroprotection from photoreceptor degeneration in response to chronic light intensity was evaluated. Subretinal delivery of EIAV vectors in the mouse lead to gene transfer and expression in photoreceptors and RPE cells. In the shaker1 mouse model lacking functional Myo7A, subretinal delivery of the UshStat � protected photoreceptors from intense light damage as indicated by reduced photoreceptor cell loss and restored threshold for translocation of alpha-transducin in the photoreceptors. UshStat � tolerability in the macaque following the subretinal injection is ongoing. We have shown that subretinal delivery of UshStat � is able to restore the alpha-transducin translocation phenotype in the shaker1 mouse model and neuroprotect the photoreceptors from high light intensity damage. These data support the development of an EIAV-based gene replacement therapy to treat Usher type 1B syndrome.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical and Experimental Ophthalmology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Experimental Ophthalmology
  • SubjectOphthalmology & Optometry
  • BylineArticles whose byline prints “Dominic Cosgrove”
  • BylineArticles whose byline prints “Marisa Zallocchi”
  • BylineArticles whose byline prints “Katie Binley”
  • BylineArticles whose byline prints “Yatish Lad”
  • BylineArticles whose byline prints “Scott Ellis”
  • BylineArticles whose byline prints “Sylvie Wise”
  • BylineArticles whose byline prints “Martin Bussi�res”
  • BylineArticles whose byline prints “Peter Widdowson”